MentalHealthDaily

9 New Anxiety Medications (2018): Drugs In Clinical Trials

Collected data from the Anxiety and Depression Association of America (ADAA) suggests that upwards of 40 million adults are affected by anxiety, or approximately 18% of the United States population. Among the 40 million adults who are affected by anxiety, it is estimated that approximately: 19 million suffer from specific phobias; 15 million suffer from …

Travivo (Gepirone ER) For Depression & Anxiety

by GLOOM

Travivo (Gepirone ER) is a pharmaceutical medication of the “azapirone” classification exhibiting a combination of anxiolytic, antidepressant, and libido-enhancing properties, similar to the drug Buspar (Buspirone). It was originally synthesized in 1986 by the company Bristol-Myers Squibb, and its licensing rights were acquired by the company Fabre-Kramer in 1993. In 1998, Fabre-Kramer out-licensed Gepirone to …